Grand Pharma Sphere

Grand Pharma Sphere appears to be a private holding company structure used by Grand Pharmaceutical Group in Singapore and Australia in connection with its ownership of Sirtex and related oncology assets. Public disclosures indicate Grand Pharma Sphere Pte. Ltd. functions as Sirtex HoldCo, the holding entity for Sirtex Medical, a commercial radiopharmaceutical business centered on SIR-Spheres Y-90 resin microspheres for liver cancer. The entity is therefore healthcare related, but it does not appear to operate as a standalone drug-development biotech with its own distinct branded pipeline separate from Sirtex and Grand Pharma. Its strategic role is to hold and finance international oncology and interventional oncology assets within the broader Grand Pharma group.